Relationship Between Rapid Skin Clearance and Quality of Life Benefit: Post Hoc Analysis of Japanese Patients with Moderate-to-Severe Psoriasis Treated with Ixekizumab (UNCOVER-J)

Lignende værker

• Efficacy and safety of ixekizumab treatment in Japanese patients with moderate‐to‐severe plaque psoriasis: Subgroup analysis of a placebo‐controlled, phase 3 study (UNCOVER‐1)
  af: Imafuku, Shinichi, et al.
  Udgivet: (2017)
• Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open‐label, phase 3 study (UNCOVER‐J)
  af: Okubo, Y., et al.
  Udgivet: (2018)
• Long‐term efficacy and safety results from an open‐label phase III study (UNCOVER‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab
  af: Umezawa, Y., et al.
  Udgivet: (2018)
• Efficacy and Safety of Ixekizumab Through 5 Years in Moderate-to-Severe Psoriasis: Long-Term Results from the UNCOVER-1 and UNCOVER-2 Phase-3 Randomized Controlled Trials
  af: Leonardi, Craig, et al.
  Udgivet: (2020)
• Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis
  af: Hawkes, Jason E., et al.
  Udgivet: (2021)